Evidence map›Paper›PMID 36196603›Full record

ArticleDermatologic therapy2022

Pityriasis rubra pilaris (type I) following administration of the BNT162b2 mRNA COVID-19 vaccine: Successful treatment with ustekinumab and acitretin.

Shirley Braga Lima Gamonal, Nathália Couri Vieira Marques, Heitor Motta Bini Pereira, Aloisio Carlos Couri Gamonal

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Shirley Braga Lima GamonalDepartment of Dermatology, Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil.ORCID 0000-0003-1575-5214
Nathália Couri Vieira MarquesFaculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil.ORCID 0000-0001-6310-0111
Heitor Motta Bini PereiraDepartment of Dermatology, School of Medical Sciences and Health of Juiz de Fora (FCMS/JF), Juiz de Fora, Brazil.ORCID 0000-0001-9845-4876
Aloisio Carlos Couri GamonalDepartment of Dermatology, Faculty of Medicine, Federal University of Juiz de Fora (UFJF), Juiz de Fora, Brazil.ORCID 0000-0002-5893-8283

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Pityriasis Rubra PilarisAcitretinBNT162 VaccineCOVID-19 VaccinesHumansRNA, MessengerUstekinumabAcitretinBNT162 VaccineCOVID-19 VaccinesRNA, MessengerUstekinumab

Identifiers

PMID36196603
PMCPMC9874643

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.